Sandbox:Dhiran: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
==Syncope ==
==Syncope ==


===Cardiac=== - <ref name="Dahi2012">{{cite journal|last1=Dahi|first1=Parastoo B|title=Correlation between the proportion of breast volume involved by locally advanced tumors and invasion of the skin and posterior structures|journal=World Journal of Clinical Oncology|volume=3|issue=3|year=2012|pages=43|issn=2218-4333|doi=10.5306/wjco.v3.i3.43}}</ref>
===Cardiac=== <ref name="Dahi2012">{{cite journal|last1=Dahi|first1=Parastoo B|title=Correlation between the proportion of breast volume involved by locally advanced tumors and invasion of the skin and posterior structures|journal=World Journal of Clinical Oncology|volume=3|issue=3|year=2012|pages=43|issn=2218-4333|doi=10.5306/wjco.v3.i3.43}}</ref>




===Nerologic===
===Nerologic=== <ref name="pmid22442757">{{cite journal |vauthors=Dahi PB, Dhiran KP, Axiotis CA, Weedon J, El-Tamer M, Sidhu G, Braverman AS |title=Correlation between the proportion of breast volume involved by locally advanced tumors and invasion of the skin and posterior structures |journal=World J Clin Oncol |volume=3 |issue=3 |pages=43–7 |date=March 2012 |pmid=22442757 |pmc=3309892 |doi=10.5306/wjco.v3.i3.43 |url=}}</ref>


==Prognosis==
==Prognosis==

Revision as of 14:50, 17 January 2021

Syncope

===Cardiac=== [1]


===Nerologic=== [2]

Prognosis

The outcome of patients with AMI-CS depends on the duration of the shock and the metabolic derangements noted.

ami

hf

myocarditis

  1. Dahi, Parastoo B (2012). "Correlation between the proportion of breast volume involved by locally advanced tumors and invasion of the skin and posterior structures". World Journal of Clinical Oncology. 3 (3): 43. doi:10.5306/wjco.v3.i3.43. ISSN 2218-4333.
  2. Dahi PB, Dhiran KP, Axiotis CA, Weedon J, El-Tamer M, Sidhu G, Braverman AS (March 2012). "Correlation between the proportion of breast volume involved by locally advanced tumors and invasion of the skin and posterior structures". World J Clin Oncol. 3 (3): 43–7. doi:10.5306/wjco.v3.i3.43. PMC 3309892. PMID 22442757.